BioCorRx Inc
OTC:BICX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kokuyo Camlin Ltd
NSE:KOKUYOCMLN
|
IN |
|
Gaotu Techedu Inc
NYSE:GOTU
|
CN |
|
Nexus AG
XETRA:NXU
|
DE |
|
S
|
Shenzhen Anche Technologies Co Ltd
SZSE:300572
|
CN |
BioCorRx Inc
Other Receivables
BioCorRx Inc
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BioCorRx Inc
OTC:BICX
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Universal Health Services Inc
NYSE:UHS
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Encompass Health Corp
NYSE:EHC
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
Other Receivables
$609m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
261%
|
CAGR 10-Years
56%
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioCorRx Inc
Glance View
BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. The company is headquartered in Anaheim, California. The company went IPO on 2010-08-31. The firm's BioCorRx Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. The company is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Its products include BICX101 and BICX104. Its lead candidate, BICX101, is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. The company is also developing an implantable naltrexone treatment, BICX104, a long-acting naltrexone implant that can last several months for the treatment of opioid dependence and alcohol use disorders. Its subsidiary is BioCorRx Pharmaceuticals, Inc.
See Also
What is BioCorRx Inc's Other Receivables?
Other Receivables
0
USD
Based on the financial report for Dec 31, 2025, BioCorRx Inc's Other Receivables amounts to 0 USD.
